Summary:
- The article discusses the FDA's new streamlined framework for approving biosimilar and interchangeable biological products, known as the "Platinum Standard" approach.
- This framework aims to expedite the review and approval process for these types of products, which are highly similar to previously approved biological drugs, but often more affordable.
- The article explains how this new approach can help increase patient access to safe and effective biological treatments, while maintaining high standards of quality and safety.